Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001942298 | SCV002229308 | pathogenic | not provided | 2023-07-28 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu363Argfs*4) in the HPS4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HPS4 are known to be pathogenic (PMID: 12664304). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 1455295). This variant has not been reported in the literature in individuals affected with HPS4-related conditions. This variant is present in population databases (rs773968140, gnomAD 0.02%). |
Baylor Genetics | RCV003471166 | SCV004192348 | likely pathogenic | Hermansky-Pudlak syndrome 4 | 2023-05-28 | criteria provided, single submitter | clinical testing |